What Has Been the Growth of the Epidural Abscess Treatment Market So Far?
The epidural abscess treatment market has seen considerable growth due to a variety of factors.
• In the last few years, growth has been robust in the epidural abscess treatment market, with a surge from $41.11 billion in 2024 to $44.01 billion in 2025 expected. This corresponds to a compound annual growth rate (CAGR) of 7.1%.
The historic growth can be credited to factors such as the rising incidence of epidural abscesses, significant healthcare spending, better disease awareness, and increased demand for combination therapies.
What Is the Forecasted Market Size and Growth Rate for The Epidural Abscess Treatment Market Size In The Coming Years?
The epidural abscess treatment market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for epidural abscess treatment is predicted to experience substantial growth. It's projected to augment to $56.78 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.6%.
This growth during the forecast period could be owing to an increase in the elderly population, initiatives from the government, funds directed towards epidural abscess research and development, and an escalating incidence of spinal epidural abscesses. Key trends expected during the forecast period incorporate advancements in healthcare technology, the application of digital health technologies in epidural abscess care, the use of artificial intelligence (AI) in diagnosing and treating epidural abscess, and affordable options for epidural abscess treatment.
What Factors Are Driving Growth In The Epidural Abscess Treatment Market?
The growth of the epidural abscess treatment market is likely to be spurred in the future by an uptick in neurological disorders. Neurological disorders impact the nervous system, including the brain, spinal cord, and nerves, with conditions such as acute spinal cord injury, Alzheimer's Disease, and Amyotrophic Lateral Sclerosis (ALS) being common. Epidural abscess treatment is necessary for these disorders as it involves immediate surgical drainage of the abscess and the use of antibiotics to avert spinal cord and nerve compression and alleviate pressure. As per the Alzheimer's Association's March 2022 report, it's predicted that by 2023, 6.7 million aged 65 or more will be living with Alzheimer's in America, a number expected to swell to 12.7 million by 2050. Consequently, the growing prevalence of neurological disorders spells an uptick in the epidural abscess treatment market. The escalating use of intravenous drugs is also predicted to fuel the epidural abscess treatment market's growth. Injecting drugs directly into the bloodstream via a hypodermic needle and syringe is what constitutes intravenous drug use. The introduction of bacteria or pathogens into the bloodstream through contaminated injecting equipment or drugs can result in epidural abscess, boosting the need for specialized care, treatments, and prevention. The Australian Institute of Health and Welfare reported in 2024 that between 2022- 2023, 1.4% of individuals aged 14 or more admitted to drug injection at least once during their lifetimes, with 0.2% injecting drugs in the past year. Hence, the rising practice of intravenous drug use is expected to stimulate the epidural abscess treatment market's growth.
What Are The Main Segments Of The Global Epidural Abscess Treatment Market?
The epidural abscess treatment market covered in this report is segmented –
1) By Type: Intracranial, Intraspinal
2) By Treatment: Antifungal, Antibiotics, Surgery
3) By End-User: Hospital, Pharmacy, Specialty Clinics, Other End-Users
Subsegments:
1) By Intracranial: Brain Abscess, Subdural Abscess, Epidural Abscess in the Cranium
2) By Intraspinal: Cervical Epidural Abscess, Thoracic Epidural Abscess, Lumbar Epidural Abscess, Sacral Epidural Abscess
Pre-Book The Epidural Abscess Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Epidural Abscess Treatment Market?
Major companies operating in the epidural abscess treatment market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Astellas Pharma
• Daiichi Sankyo Company Limited
• Boehringer Ingelheim International GmbH
• UCB Pharma
• Sun Pharmaceutical Industries Limited
• Kyowa Hakko Kirin Co. Ltd.
• Ferring B.V.
• Hikma Pharmaceuticals PLC
• Intas Pharmaceuticals Limited
• Alembic Limited
• Zydus Lifesciences Ltd.
• Lupin Limited
• Mallinckrodt Pharmaceuticals.
What Is The Most Dominant Region In The Epidural Abscess Treatment Market?
North America was the largest region in the epidural abscess treatment market in 2024. The regions covered in epidural abscess treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
